Igene Biotechnology Inc (Over The Counter Market:IGNE)

0.0001
Delayed Data
As of Aug 02
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
0.00
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2006

2007

2008

2009
Revenue and IncomeNet Revenues0.002.3M7.6M4.0M
 
 
 
 
Cost of Goods Sold0.001.7M6.0M2.8M
 
 
 
 
Depreciation And Amortization16.5K12.4K372.3K181.5K
 
 
 
 
 
 
Operating ExpensesGross Income-16.5K605.1K1.2M1.0M
 
 
 
 
 
General Expenses2.0M2.1M3.4M3.1M
 
 
 
 
 
Research And Development847.6K983.6K1.7M1.9M
 
 
 
 
 
Total Operating Expenses2.0M3.8M9.8M6.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-1.5M-2.2M-2.1M
 
 
 
 
 
Extraordinary Credit0.000.000.001.0M
 
 
Pre-Tax Equity Earnings-109.1K170.8K0.00-1.1M
 
 
 
 
Interest Expense On Debt831.8K2.2M2.0M97.5K
 
 
 
 
 
Other Expenses1.7M1.6M225.8K2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-1.9M-4.0M-140.7K
 
 
 
 
 
Net Income-1.2M-1.9M-4.0M-140.7K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.4M109.7M187.0M1.5B
 
 
 
 
 
Shares To Calculate EPS Diluted103.4M109.7M187.0M1.5B
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01-$0.02-$0.02--
 
 
 
 
EPS Diluted-$0.01-$0.02-$0.02$0.00